1. Home
  2. HP vs HCM Comparison

HP vs HCM Comparison

Compare HP & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helmerich & Payne Inc.

HP

Helmerich & Payne Inc.

HOLD

Current Price

$32.40

Market Cap

2.9B

Sector

Energy

ML Signal

HOLD

Logo HUTCHMED (China) Limited

HCM

HUTCHMED (China) Limited

HOLD

Current Price

$16.04

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HP
HCM
Founded
1920
2000
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HP
HCM
Price
$32.40
$16.04
Analyst Decision
Hold
Sell
Analyst Count
11
1
Target Price
$30.27
$13.75
AVG Volume (30 Days)
1.4M
55.1K
Earning Date
02-04-2026
08-07-2025
Dividend Yield
3.10%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.53
Revenue
$3,746,013,000.00
$602,197,000.00
Revenue This Year
$9.18
N/A
Revenue Next Year
$3.91
$15.54
P/E Ratio
N/A
$5.57
Revenue Growth
35.89
N/A
52 Week Low
$14.65
$11.51
52 Week High
$37.30
$19.50

Technical Indicators

Market Signals
Indicator
HP
HCM
Relative Strength Index (RSI) 67.60 75.72
Support Level $31.40 $14.63
Resistance Level $32.97 $15.00
Average True Range (ATR) 1.20 0.42
MACD 0.22 0.26
Stochastic Oscillator 89.87 90.63

Price Performance

Historical Comparison
HP
HCM

About HP Helmerich & Payne Inc.

Helmerich & Payne Inc provides performance-driven drilling solutions and technologies to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. Focusing on the drilling segment, its technology services develop and commercialize solutions that improve drilling efficiency, accuracy, and wellbore quality and placement. The company operates through North America Solutions, International Solutions, and Offshore Solutions segments. The North America segment runs a technologically advanced AC drive drilling rig fleet in the U.S., with a presence in shale and unconventional basins, while the Offshore Solutions segment, operating rigs on fixed-leg and floating platforms, generates the majority of revenue.

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

Share on Social Networks: